TY - JOUR
AU - R. M. Rosenfeld
AU - M. L. Grega
AU - M. C. Karlsen
AU - A. M. Abu Dabrh
AU - R. N. Aurora
AU - J. P. Bonnet
AU - L. Donnell
AU - S. L. Fitzpatrick
AU - B. Frates
AU - E. A. Joy
AU - J. F. Kapustin
AU - D. R. Noe
AU - G. Panigrahi
AU - A. Ram
AU - L. S. Levine Reisner
AU - W. M. Valencia
AU - L. J. Weatherspoon
AU - J. M. Weber
AU - K. L. Staffier
AU - M. Gulati
A1 - 
AB - This executive summary highlights evidence-based recommendations for using lifestyle interventions in the treatment and remission of type 2 diabetes (T2D) and prediabetes in adults. The summary and guideline are intended for any clinician or healthcare professional in a community or non-inpatient healthcare setting involved in managing non-pregnant adults with T2D, prediabetes or a history of gestational diabetes mellitus (GDM). The purpose of this executive summary is to provide a succinct overview of the key action statements (recommendations) from Lifestyle Interventions for Treatment and Remission of Type 2 Diabetes and Prediabetes in Adults: A Clinical Practice Guideline from the American College of Lifestyle Medicine. This is the first diabetes guideline to emphasize lifestyle interventions as the foundation of management and is also the first to focus on all six pillars of lifestyle medicine (plant-predomination nutrition, regular physical activity, restorative sleep, stress reduction, social connectedness, and avoiding risky substances), including behavior change strategies. This summary is not intended to substitute for the full guideline, which should be read before taking the recommended actions. The guideline on which this summary is based was developed with a priori methodology that has been previously published, refined, and used in over 20 multidisciplinary, trustworthy, and evidence-based national guidelines. The guideline development group included 20 members representing consumers, advanced practice nursing, cardiology, clinical pharmacology, behavioral medicine, endocrinology, family medicine, lifestyle medicine, nutrition and dietetics, health education, health and wellness coaching, sleep medicine, sports medicine, and obesity medicine. We developed 14 key action statements and associated evidence profiles, each with a distinct quality improvement goal in the context of lifestyle interventions for T2D. Strong recommendations were made regarding advocacy for lifestyle interventions; assessing baseline lifestyle habits; establishing priorities for lifestyle change; prescribing aerobic and muscle strength physical activity; reducing sedentary time; identifying sleep disorders; prescribing nutrition plans for prevention and treatment; promoting peer/familial support and social connections; counseling regarding tobacco, alcohol, and recreational drugs, and establishing a plan for continuity of care. Recommendations were made regarding identifying the need for psychological interventions and for adjusting (deprescribing) pharmacologic therapy. We include numerous tables and figures to facilitate implementation, a plain-language summary for consumers, and an executive summary for clinicians as separate publications. Although not a substitute for the full clinical practice guideline, this executive summary can provide insight into the key guideline recommendations, to whom they apply, and to how they might alter care. These recommendations offer detailed, explicit, and evidence-based strategies for successful lifestyle behavior change, making them relevant not only to our guideline but to other guidelines and standards that advocate for lifestyle change in managing adults with T2D.
AD - Department of Otolaryngology, SUNY Downstate Health Sciences University, Brooklyn NY, USA (RMR).; Department of Community and Family Medicine, Kellyn Foundation, Tatamy, PA, USA (MLG).; Department of Research, American College of Lifestyle Medicine, Chesterfield, MO, USA (MCK, KLS).; Division of Nephrology and Hypertension/Division of General Internal Medicine, Mayo Clinic, Jacksonville, FL, USA (AMAD). RINGGOLD: 156400; Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, NYU Grossman School of Medicine, New York, NY, USA (RNA). RINGGOLD: 12296; Department of Medicine and Division of Primary Care and Population Health, Stanford University School of Medicine/Movietime Clinic, Palo Alto Veterans Affairs, Palo Alto, CA, USA (JPB).; SUNY Downstate Health Sciences University, Brooklyn, NY, USA (LD).; Northwell, New Hyde Park, NY, USA (SLF).; Department of Physical Medicine and Rehabilitation, Harvard Medical School/Spaulding Rehabilitation Hospital, Charlestown, MA, USA (BF).; Lore Health, San Diego, CA, USA (EAJ).; Riverside Medical, Riverdale, MD, USA (JFK).; Dawn Noe Nutrition and Consulting, Cleveland, OH, USA (DRN).; Department of Internal Medicine, Eastern Virginia Medical School, Norfolk, VA (GP). RINGGOLD: 6040; Sentara Cardiology Specialists, Virginia Beach, VA, USA (GP).; Department of Biomedical and Translational Sciences, Macon & Joan Brock Virginia Health Sciences, Eastern Virginia Medical School at Old Dominion University, Norfolk, VA, USA (AR).; Plant Powered Metro New York, New York, NY, USA (LSLR).; Department of Endocrinology and Metabolism, Cleveland Clinic, Cleveland, OH, USA (WMV). RINGGOLD: 2569; Department of Food Science and Human Nutrition, Michigan State University, East Lansing, MI, USA (LJW). RINGGOLD: 3078; Department of Medicine, Sections of General Internal Medicine and Endocrinology & Metabolism, Yale School of Medicine, New Haven, CT, USA (JMW). RINGGOLD: 12228; Department of Medicine, Division of Endocrinology, Diabetes, Metabolism, UConn Health, Farmington, CT, USA (MG).
AN - 40546763
BT - Am J Lifestyle Med
C5 - Education & Workforce
CP - 2 Suppl
DA - Jul
DO - 10.1177/15598276251325485
DP - NLM
ET - 20250610
IS - 2 Suppl
JF - Am J Lifestyle Med
LA - eng
N2 - This executive summary highlights evidence-based recommendations for using lifestyle interventions in the treatment and remission of type 2 diabetes (T2D) and prediabetes in adults. The summary and guideline are intended for any clinician or healthcare professional in a community or non-inpatient healthcare setting involved in managing non-pregnant adults with T2D, prediabetes or a history of gestational diabetes mellitus (GDM). The purpose of this executive summary is to provide a succinct overview of the key action statements (recommendations) from Lifestyle Interventions for Treatment and Remission of Type 2 Diabetes and Prediabetes in Adults: A Clinical Practice Guideline from the American College of Lifestyle Medicine. This is the first diabetes guideline to emphasize lifestyle interventions as the foundation of management and is also the first to focus on all six pillars of lifestyle medicine (plant-predomination nutrition, regular physical activity, restorative sleep, stress reduction, social connectedness, and avoiding risky substances), including behavior change strategies. This summary is not intended to substitute for the full guideline, which should be read before taking the recommended actions. The guideline on which this summary is based was developed with a priori methodology that has been previously published, refined, and used in over 20 multidisciplinary, trustworthy, and evidence-based national guidelines. The guideline development group included 20 members representing consumers, advanced practice nursing, cardiology, clinical pharmacology, behavioral medicine, endocrinology, family medicine, lifestyle medicine, nutrition and dietetics, health education, health and wellness coaching, sleep medicine, sports medicine, and obesity medicine. We developed 14 key action statements and associated evidence profiles, each with a distinct quality improvement goal in the context of lifestyle interventions for T2D. Strong recommendations were made regarding advocacy for lifestyle interventions; assessing baseline lifestyle habits; establishing priorities for lifestyle change; prescribing aerobic and muscle strength physical activity; reducing sedentary time; identifying sleep disorders; prescribing nutrition plans for prevention and treatment; promoting peer/familial support and social connections; counseling regarding tobacco, alcohol, and recreational drugs, and establishing a plan for continuity of care. Recommendations were made regarding identifying the need for psychological interventions and for adjusting (deprescribing) pharmacologic therapy. We include numerous tables and figures to facilitate implementation, a plain-language summary for consumers, and an executive summary for clinicians as separate publications. Although not a substitute for the full clinical practice guideline, this executive summary can provide insight into the key guideline recommendations, to whom they apply, and to how they might alter care. These recommendations offer detailed, explicit, and evidence-based strategies for successful lifestyle behavior change, making them relevant not only to our guideline but to other guidelines and standards that advocate for lifestyle change in managing adults with T2D.
PY - 2025
SN - 1559-8276 (Print); 1559-8276
SP - 132s
EP - 154s+
ST - Executive Summary of Lifestyle Interventions for Treatment and Remission of Type 2 Diabetes and Prediabetes in Adults: A Clinical Practice Guideline From the American College of Lifestyle Medicine
T1 - Executive Summary of Lifestyle Interventions for Treatment and Remission of Type 2 Diabetes and Prediabetes in Adults: A Clinical Practice Guideline From the American College of Lifestyle Medicine
T2 - Am J Lifestyle Med
TI - Executive Summary of Lifestyle Interventions for Treatment and Remission of Type 2 Diabetes and Prediabetes in Adults: A Clinical Practice Guideline From the American College of Lifestyle Medicine
U1 - Education & Workforce
U3 - 10.1177/15598276251325485
VL - 19
VO - 1559-8276 (Print); 1559-8276
Y1 - 2025
ER -